Cutting Drug Prices to Deter Firms From Manufacturing: Biocon Head
Biocon chairperson and managing director Kiran Mazumdar Shaw has raised concerns that the new government's intention to bring down prices of essential drugs by 25-40 per cent could deter manufacturing of such medicines by companies.
While taking charge, Fertiliser and Chemicals Minister Ananth Kumar had said that he would talk to pharmaceutical companies and try to bring down prices of essential drugs by 25-40 per cent.
"Minister Ananth Kumar's mandate to further reduce drug prices can potentially deter quality drug makers from manufacturing essential drugs," Ms Shaw said on the micro blogging site Twitter.
She further said the minister "must factor cost of quality systems else you will get poor quality of cheap drugs".
She stressed that unless the pharma sector is spared from multiple and conflicting regulations, it will not realise global leadership potential.
"Minister Ananth Kumar should make right to healthcare a reality thru (sic) large scale drug procurement of essential drugs not thru (sic) forced rebate," she added.
Pharmaceutical industry bodies such as IPA (Indian Pharmaceutical Alliance), IDMA (Indian Drug Manufacturers' Association), however, declined to comment on the issue.
"It is too early to comment," they added.
Mr Kumar, who is also responsible for the Department of Pharmaceuticals, had said the government would talk to global pharmaceutical firms to bring down the cost of drugs.
"... as far as branded medicines of multinational pharmaceutical companies are concerned, we will talk to all of them and try to bring down prices of essential drugs for poor by 25-40 per cent," he had said.
Last year, the government had notified the new drug pricing policy, bringing 348 formulations listed in the National List of Essential Medicines (NLEM) under the price control regime thereby reducing their prices.
In the earlier policy, the government through the National Pharmaceutical Pricing Authority (NPPA) controlled prices of 74 bulk drugs and their formulations.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.